Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-11 Purchase | 2023-12-12 08:27 am | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS Director | 6,455 | $6.8523 | $44,232 | 4,559,233 (Direct) | View |
| 2023-12-07 Purchase | 2023-12-11 5:25 pm | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS Director | 127,549 | $6.9809 | $890,411 | 4,552,778 (Direct) | View |
| 2023-11-29 Purchase | 2023-12-01 5:15 pm | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS Director | 51,837 | $5.9702 | $309,477 | 4,425,229 (Direct) | View |
| 2023-11-27 Purchase | 2023-11-29 5:14 pm | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS Director | 93,187 | $5.5941 | $521,294 | 4,373,392 (Direct) | View |
| 2023-05-15 Purchase | 2023-05-17 5:05 pm | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS See remarks | 101,740 | $9.6462 | $981,404 | 4,280,205 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-16 Equity Swap | 2025-09-18 9:39 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | WG Biotech ApS Director 10% Owner | 4,559,233 | $8.6 | 0 (Direct) | View |